A mother-of-two claims to have found a "miracle" cure for her psoriasis almost three decades after first being diagnosed with ...
In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...
5d
Study Finds on MSNWhen Good Cells Turn Bad: Scientists Discover Why Psoriasis Won’t Go AwayDiscover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.
2d
MedPage Today on MSNNewer Biologics Tied to Fewer Infections for Older Patients With Psoriatic DiseaseBiologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...
Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...
Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...
3d
News-Medical.Net on MSNMediterranean diet shows promise in easing psoriasis, acne, and hidradenitis suppurativaA recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...
Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...
Dry skin, itching, and fiery eczema can be caused by allergens, stress, or an overactive immune response.Steroid creams ...
A systematic review revealed that patients with psoriasis have a significantly higher prevalence of onychomycosis than those without psoriasis.
Some evidence suggests a higher risk of liver disease with psoriasis. Certain psoriasis treatments can cause liver toxicity, but the two conditions also share common risk factors, which may ...
IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results